Progression & Recurrence for Muscle-invasive Bladder Cancer

Roughly 40% of patients with muscle-invasive bladder cancer (MIBC) undergo a radical cystectomy.This procedure is more colloquially known as bladder removal surgery. After the surgery, patients may wonder: “Is the cancer really gone, or do I need more treatment just in case?” Until recently, doctors determined post-surgery treatment plans using traditional risk factors such as […]

A new real-world study is raising important questions about whether some patients with advanced bladder cancer may benefit from adding local treatment, such as surgery or radiation, after responding to systemic therapy with enfortumab vedotin (EV) and pembrolizumab (pembro). While the findings are early and not yet practice-changing, they highlight a growing area of interest […]

Finishing treatment for muscle-invasive bladder cancer is a major milestone, but it’s not the end of your care. It’s the beginning of a new phase that plays a critical role in your long-term health. Surveillance after treatment is not about waiting for something bad to happen. It’s about being proactive with the goal to catch […]

For many people with muscle-invasive bladder cancer (MIBC), having the bladder removed, called a radical cystectomy, is one of the most important steps toward cure. It’s a major surgery, and getting through it is no small thing. One of the most common questions that comes next is simple and honest: can the cancer still come […]

Completing treatment for muscle-invasive bladder cancer (MIBC) is a major milestone, but it often comes with new concerns about what happens next. You may wonder how you’ll be monitored, what signs to watch for, and what treatment options may be available if the cancer returns. Keep reading for insights from Fox Chase Cancer Center’s Dr. […]